Clinical trials / NCT06706323
Recruiting

Depressive Symptoms After Cardiac Surgery

The primary goal of this project is to develop a predictive model for clinically significant depressive symptoms (CSDS) in patients undergoing coronary artery bypass graft (CABG) surgery, using pre- and perioperative data. CSDS occur in about 30 percent of CABG patients, which is four times higher than in the general population. These symptoms are linked to poor quality of life and increased morbidity and mortality. The aim is to create a model that can identify patients at risk for postoperative depression. This…

ClinicalTrials.gov IDNCT06706323
PhaseNot Applicable
Enrollment300
SponsorRoland von Känel
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Cardiovascular Diseases, Coronary Artery Disease, Heart Diseases, Depression, Depressive Symptoms, Anxiety, Posttraumatic Stress Disorder, Quality of Life, Psychological Well-Being, Postoperative Complications

About this study

The primary goal of this project is to develop a predictive model for clinically significant depressive symptoms (CSDS) in patients undergoing coronary artery bypass graft (CABG) surgery, using pre- and perioperative data. CSDS occur in about 30 percent of CABG patients, which is four times higher than in the general population. These symptoms are linked to poor quality of life and increased morbidity and mortality. The aim is to create a model that can identify patients at risk for postoperative depression. This tool could help clinicians make informed decisions and take preventive measures to manage depression after surgery.

Primary outcomes

Eligibility information

Inclusion Criteria: * Elective Off-Pump CABG or CABG, either isolated or combined with valve intervention * Men and women, aged between 18 and 90 years * Sufficient knowledge of German language in reading and understanding * Oral and Signed consent form * Ability and Willingness to follow the study protocol Exclusion Criteria: * Cognitive impairment according to a score of ≤ 7 (maximum score = 9) on a modified version of a short version of the Mini-Mental State Examination and the Brief Interview for Mental Status * Any serious comorbid non-cardiac medical condition likely to cause death within 1 year (e.g. metastatic cancer) * Active psychotic symptoms (assessed with two items from the Youth Psychosis At Risk Questionnaire), substance abuse and/or dependence within the past 6 months (assessed with a single-item questionnaire), and/or active suicidal ideations (assessed with a single item from the M.I.N.I.). * Acute or emergency CABG

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.